Correlation Between Arvinas and Amylyx Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Arvinas and Amylyx Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arvinas and Amylyx Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arvinas and Amylyx Pharmaceuticals, you can compare the effects of market volatilities on Arvinas and Amylyx Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arvinas with a short position of Amylyx Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arvinas and Amylyx Pharmaceuticals.

Diversification Opportunities for Arvinas and Amylyx Pharmaceuticals

0.39
  Correlation Coefficient

Weak diversification

The 3 months correlation between Arvinas and Amylyx is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Arvinas and Amylyx Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amylyx Pharmaceuticals and Arvinas is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arvinas are associated (or correlated) with Amylyx Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amylyx Pharmaceuticals has no effect on the direction of Arvinas i.e., Arvinas and Amylyx Pharmaceuticals go up and down completely randomly.

Pair Corralation between Arvinas and Amylyx Pharmaceuticals

Given the investment horizon of 90 days Arvinas is expected to generate 5.96 times less return on investment than Amylyx Pharmaceuticals. But when comparing it to its historical volatility, Arvinas is 1.55 times less risky than Amylyx Pharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. Amylyx Pharmaceuticals is currently generating about 0.28 of returns per unit of risk over similar time horizon. If you would invest  294.00  in Amylyx Pharmaceuticals on September 3, 2024 and sell it today you would earn a total of  260.00  from holding Amylyx Pharmaceuticals or generate 88.44% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Arvinas  vs.  Amylyx Pharmaceuticals

 Performance 
       Timeline  
Arvinas 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Arvinas are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady basic indicators, Arvinas may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Amylyx Pharmaceuticals 

Risk-Adjusted Performance

22 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Amylyx Pharmaceuticals are ranked lower than 22 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating essential indicators, Amylyx Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Arvinas and Amylyx Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Arvinas and Amylyx Pharmaceuticals

The main advantage of trading using opposite Arvinas and Amylyx Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arvinas position performs unexpectedly, Amylyx Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amylyx Pharmaceuticals will offset losses from the drop in Amylyx Pharmaceuticals' long position.
The idea behind Arvinas and Amylyx Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine